TEZ BIO
LIVE

Serial Number

99311084

Owner

POPVAX PRIVATE LIMITED

Attorney

Jonathan M. Rixen

Filing Date

Jul 30, 2025

Add to watchlist:

No watchlists yet
View on USPTO

TEZ BIO Trademark

Serial Number: 99311084

TEZ BIO is a trademark filed by POPVAX PRIVATE LIMITED on July 30, 2025. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

POPVAX PRIVATE LIMITED (14 trademarks)

8c lohtse chs, millitary road,

Entity Type: 99

Trademark Details

Filing Date

July 30, 2025

Registration Date

Not Registered

Published for Opposition

March 10, 2026

Goods & Services

Biological research; medical research; scientific laboratory services; scientific research; chemical research; research and development of new products for others; technological research in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; scientific, medical, biological research and development in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; conducting clinical trials for others and testing services in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; engineering services relating to research and development of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; software as a service (SaaS) services featuring computer software for designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of structure, function, sequence, dynamics, stability, and thermodynamics of nucleic acids, polynucleotides, oligonucleotides, proteins, antigens, immunogens, antibodies, nanobodies, drug conjugates, ligands, peptides, amino acids, nucleotides, nucleosides, carbohydrates, adjuvants, drug delivery carriers, lipids, polymers and formulations for use in manufacturing of pharmaceutical, vaccines, medicines, biologics, biotherapeutics, and biosimilars; creation of websites for others featuring information in the pharmaceutical, medical and health fields; hosting of a website featuring information in the pharmaceutical, medical and health fields; hosting podcasts in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; software as a service (SaaS) services featuring computer software for designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of structure, function, sequence, dynamics, stability, and thermodynamics of nucleic acids, polynucleotides, oligonucleotides, proteins, antigens, immunogens, antibodies, nanobodies, drug conjugates, ligands, peptides, amino acids, nucleotides, nucleosides, carbohydrates, adjuvants, drug delivery carriers, lipids, polymers, and formulations; software as a service (saas) services featuring computer software for use in designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of experiments related to molecular biology, cell biology, biochemistry, organic chemistry, inorganic chemistry, biophysics, immunology, sequencing, toxicology, pharmacodynamics, pharmacokinetics, biodistribution, formulation, drug delivery, bioassays, analytical assays, and analytical characterization for production or manufacturing of pharmaceutical and biopharmaceutical preparations, data management, or clinical trial management

Providing private equity and investment funding; venture capital services, namely, providing financing to emerging companies, start-up companies, small businesses, developing companies, and late-stage companies and entrepreneurs; venture capital funding services to emerging companies, start-up companies, small businesses, developing companies, and late-stage companies and entrepreneurs; venture capital funding services to pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices companies, diagnostic companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), clinical research companies, software companies, and hardware companies; providing working capital financing to businesses and business owners, namely, emerging and start-up companies; providing working capital financing to pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices companies, diagnostic companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), clinical research companies, software companies, and hardware companies; providing venture capital, development capital, private equity and investment funding to emerging companies, start-up companies, small businesses, developing companies, and late-stage companies and entrepreneurs; providing venture capital, development capital, private equity and investment funding to pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices companies, diagnostic companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), clinical research companies, software companies, and hardware companies; providing funding for joint ventures in the field of biological research, medical research, chemical research, pharmaceuticals, nutraceuticals, reagents, chemicals, enzymes, medical devices, biopharmaceuticals, vaccines, biologics, biotherapeutics, and biosimilars; providing funding for inventions in the field of biological research, medical research, chemical research, pharmaceuticals, nutraceuticals, reagents, chemicals, enzymes, medical devices, biopharmaceuticals, vaccines, biologics, biotherapeutics, and biosimilars; providing funding for research, development, and commercialization of products and services in the field of biological research, medical research, chemical research, pharmaceuticals, nutraceuticals, reagents, chemicals, enzymes, medical devices, biopharmaceuticals, vaccines, biologics, biotherapeutics, and biosimilars; providing project grants for research, development, and commercialization of products and services in the field of biological research, medical research, chemical research, pharmaceuticals, nutraceuticals, reagents, chemicals, enzymes, medical devices, biopharmaceuticals, vaccines, biologics, biotherapeutics, and biosimilars; equity capital investment; loan financing of business ventures; creation and management of venture capital investment funds that invest in emerging companies, start-up companies, small businesses, developing companies, and late-stage companies, and entrepreneurs; creation and management of venture capital investment funds that invest in pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices companies, diagnostic companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), clinical research companies, software companies, and hardware companies

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 5, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 10, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 10, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 4, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 17, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 13, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 15, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 15, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 15, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 15, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 8, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 30, 2025 MAFR
NEW APPLICATION ENTERED
Jul 30, 2025 NWAP